Brief: Werewolf Therapeutics Provides Business Update And Highlights 2024 Strategic Outlook

Werewolf Therapeutics

08/01/2024 13:23

Jan 8 (Reuters) - Werewolf Therapeutics Inc  HOWL.O :
    * WEREWOLF THERAPEUTICS PROVIDES BUSINESS UPDATE AND
HIGHLIGHTS
2024 STRATEGIC OUTLOOK
    * WEREWOLF THERAPEUTICS- PRIORITIZING DEVELOPMENT OF WHOLLY
OWNED
CLINICAL ASSETS, WTX-124 AND WTX-330; KEY UPDATES FROM BOTH
PROGRAMS EXPECTED IN 2024
    * WEREWOLF THERAPEUTICS INC - WTX-330: PRELIMINARY
DOSE-ESCALATION
DATA FROM PHASE 1 CLINICAL TRIAL EXPECTED IN 2Q 2024
    * WEREWOLF THERAPEUTICS INC - UPDATED CASH GUIDANCE PROVIDES
RUNWAY THROUGH AT LEAST Q1 OF 2025

Source text for Eikon:  ID:nGNX6kJd3T 
Further company coverage:  HOWL.O 

 ((Reuters.Briefs@thomsonreuters.com;))